![PPT - Early And Long Term Treatment With Clopidogrel In Coronary Artery Disease PowerPoint Presentation - ID:475326 PPT - Early And Long Term Treatment With Clopidogrel In Coronary Artery Disease PowerPoint Presentation - ID:475326](https://image.slideserve.com/475326/overall-study-design-credo-l.jpg)
PPT - Early And Long Term Treatment With Clopidogrel In Coronary Artery Disease PowerPoint Presentation - ID:475326
![PPT - Lack of Evidence of a Clopidogrel – Statin Interaction in the CHARISMA Trial PowerPoint Presentation - ID:3918839 PPT - Lack of Evidence of a Clopidogrel – Statin Interaction in the CHARISMA Trial PowerPoint Presentation - ID:3918839](https://image2.slideserve.com/3918839/lack-of-evidence-of-a-clopidogrel-statin-interaction-in-the-charisma-trial-l.jpg)
PPT - Lack of Evidence of a Clopidogrel – Statin Interaction in the CHARISMA Trial PowerPoint Presentation - ID:3918839
![C.R.E.D.O. C lopidogrel for the R eduction of E vents D uring O bservation Multicenter Multinational (USA, Canada) Prospective Randomized Double Blind. - ppt download C.R.E.D.O. C lopidogrel for the R eduction of E vents D uring O bservation Multicenter Multinational (USA, Canada) Prospective Randomized Double Blind. - ppt download](https://images.slideplayer.com/24/7043962/slides/slide_23.jpg)
C.R.E.D.O. C lopidogrel for the R eduction of E vents D uring O bservation Multicenter Multinational (USA, Canada) Prospective Randomized Double Blind. - ppt download
![Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3) - American Journal of Cardiology Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3) - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c9e980e8-e518-4acb-a8ac-c52d55007be5/gr1_lrg.jpg)
Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3) - American Journal of Cardiology
![Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study - Clinical Therapeutics Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5fe49eab-4e2e-423e-b65e-e64c75c18a51/gr1_lrg.jpg)
Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study - Clinical Therapeutics
![Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial - ScienceDirect Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109707009928-gr1.jpg)
Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial - ScienceDirect
![Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [ Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4485f809-e81d-4a85-a166-38d3a652f2c2/gr1.jpg)
Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [
![Long-term effect of clopidogrel in patients with and without diabetes: A systematic review and meta-analysis of randomized controlled trials Long-term effect of clopidogrel in patients with and without diabetes: A systematic review and meta-analysis of randomized controlled trials](https://f6publishing.blob.core.windows.net/ba9328b8-3ddf-4a84-8bf0-ed57d1bce79e/WJD-11-137-g005.png)
Long-term effect of clopidogrel in patients with and without diabetes: A systematic review and meta-analysis of randomized controlled trials
![Pharmacology in Acute Coronary Syndromes: Anti-platelet Agents Tim Kinnaird, University Hospital Wales, Cardiff and Vale NHS Trust. - ppt download Pharmacology in Acute Coronary Syndromes: Anti-platelet Agents Tim Kinnaird, University Hospital Wales, Cardiff and Vale NHS Trust. - ppt download](https://images.slideplayer.com/15/4583024/slides/slide_11.jpg)
Pharmacology in Acute Coronary Syndromes: Anti-platelet Agents Tim Kinnaird, University Hospital Wales, Cardiff and Vale NHS Trust. - ppt download
![Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/52f9973d-b804-4188-86b8-0ab390822191/e008307fig06.jpg)
Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions
The Cost-Effectiveness of Dual Oral Antiplatelet Therapy following Percutaneous Coronary Intervention: A Swedish Analysis of the
![Study flow. CABG indicates coronary artery bypass grafting; CREDO-Kyoto... | Download Scientific Diagram Study flow. CABG indicates coronary artery bypass grafting; CREDO-Kyoto... | Download Scientific Diagram](https://www.researchgate.net/publication/337150245/figure/fig1/AS:826996854624256@1574182823466/Study-flow-CABG-indicates-coronary-artery-bypass-grafting-CREDO-Kyoto-PCI-CABG.png)